Cancer Health Fall Issue

Findings on nearly 4,000 BRCA1 mutations will be immediately useful to many patients with previously inconclusive genetic test results.

New target identified in glioblastoma could be effective against a common immortality mechanism in one third of cancers.

September is Prostate Cancer Awareness Month and the perfect time to learn more about this common cancer.

Fred Hutch researcher zeroes in on biomarkers to better predict aggressive form of the disease.

“The Real Cost” campaign to target nearly 10.7 million at-risk youth through digital platforms, social media and in-school ads nationwide.

So far, only a small proportion of cancers have known driver mutations, despite the best effort of hundreds of researchers worldwide.

The search continues for new biomarkers, better outcomes and, yes, cures for this deadly disease.

Use of medications like Prilosec and Nexium were associated with a higher liver cancer rate in a recent large study.

The test may allow doctors to choose the best therapeutic option for a patient within days or weeks, rather than months.

Latonya Wilson advocates for better understanding of metastatic breast cancer and more outreach to African Americans.